Clinical metagenomic analysis and cancer.

Abstract

After seven years of periodic controls by the SEIMC (Spanish Society of Infectious Diseases and Clinical Microbiology), it can be affirmed that the analysis is capable of detecting microorganisms in any type of sample (Blood, CSF, Saliva, BAL, Urine, Sputum, Faeces, Tissues, Prosthetic Material, Exudates, Swabs, Etc…), it requires a small amount of sample, it identifies more than 77,000 pathogens in a single test, simultaneously detects Archaea, G+ and G- Bacteria, Fungi, Viruses, Protists and parasites, it detects nonculturable pathogens and those that revert to false negatives, it is not affected by inhibition by antibiotics or other causes, resistance to antibiotics and antimycotics are detected, results are obtained in 24 hours, it is the most sensitive and reliable direct microbial identification technique and specific today.

The analysis is 87% more sensitive than a culture, 99% reliable in gender determination, 91% reliable in sensitivity, increases the rate of accurate diagnosis of infections by more than 50%, as it is NGS sequencing it is more sensitive, specific and reliable than 16s and 18s sequencing. The test is highly useful for detecting microorganisms associated with cancer.